Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 7 studies | 23% ± 3% | |
| adipocyte | 5 studies | 21% ± 3% | |
| GABAergic neuron | 4 studies | 32% ± 6% | |
| glutamatergic neuron | 4 studies | 33% ± 2% | |
| ciliated cell | 4 studies | 31% ± 9% | |
| cardiac muscle cell | 3 studies | 20% ± 4% | |
| retinal rod cell | 3 studies | 42% ± 8% | |
| T cell | 3 studies | 20% ± 3% | |
| endothelial cell of vascular tree | 3 studies | 37% ± 4% | |
| astrocyte | 3 studies | 33% ± 15% | |
| club cell | 3 studies | 21% ± 1% | |
| type I pneumocyte | 3 studies | 25% ± 3% | |
| basal cell | 3 studies | 32% ± 16% | |
| interneuron | 3 studies | 38% ± 7% | |
| plasma cell | 3 studies | 25% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adrenal gland | 100% | 1003.58 | 258 / 258 | 18% | 0.43 | 41 / 230 |
| ovary | 100% | 972.89 | 180 / 180 | 9% | 0.15 | 38 / 430 |
| lung | 98% | 138.94 | 568 / 578 | 9% | 0.17 | 108 / 1155 |
| thymus | 100% | 146.93 | 650 / 653 | 8% | 0.13 | 46 / 605 |
| esophagus | 85% | 82.30 | 1230 / 1445 | 22% | 0.35 | 40 / 183 |
| kidney | 100% | 234.45 | 89 / 89 | 5% | 0.13 | 48 / 901 |
| uterus | 99% | 263.01 | 168 / 170 | 6% | 0.09 | 28 / 459 |
| prostate | 99% | 319.36 | 242 / 245 | 4% | 0.07 | 21 / 502 |
| breast | 100% | 183.63 | 457 / 459 | 1% | 0.03 | 14 / 1118 |
| spleen | 100% | 324.81 | 241 / 241 | 0% | 0 | 0 / 0 |
| pancreas | 95% | 251.25 | 311 / 328 | 5% | 0.08 | 9 / 178 |
| adipose | 100% | 200.47 | 1198 / 1204 | 0% | 0 | 0 / 0 |
| bladder | 86% | 196.00 | 18 / 21 | 10% | 0.18 | 51 / 504 |
| muscle | 95% | 171.91 | 766 / 803 | 0% | 0 | 0 / 0 |
| skin | 72% | 102.74 | 1302 / 1809 | 22% | 0.65 | 103 / 472 |
| stomach | 81% | 71.31 | 292 / 359 | 9% | 0.17 | 27 / 286 |
| peripheral blood | 83% | 195.71 | 767 / 929 | 0% | 0 | 0 / 0 |
| intestine | 77% | 113.71 | 741 / 966 | 5% | 0.08 | 27 / 527 |
| heart | 76% | 58.77 | 657 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 72% | 3.14 | 21 / 29 |
| liver | 62% | 78.32 | 139 / 226 | 1% | 0.01 | 3 / 406 |
| blood vessel | 51% | 32.65 | 682 / 1335 | 0% | 0 | 0 / 0 |
| brain | 41% | 36.40 | 1082 / 2642 | 5% | 0.18 | 36 / 705 |
| tonsil | 0% | 0 | 0 / 0 | 9% | 0.18 | 4 / 45 |
| eye | 0% | 0 | 0 / 0 | 5% | 0.11 | 4 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0051091 | Biological process | positive regulation of DNA-binding transcription factor activity |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0007165 | Biological process | signal transduction |
| GO_0071391 | Biological process | cellular response to estrogen stimulus |
| GO_0071392 | Biological process | cellular response to estradiol stimulus |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0007267 | Biological process | cell-cell signaling |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_0006355 | Biological process | regulation of DNA-templated transcription |
| GO_0030308 | Biological process | negative regulation of cell growth |
| GO_0030520 | Biological process | estrogen receptor signaling pathway |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0000785 | Cellular component | chromatin |
| GO_0005634 | Cellular component | nucleus |
| GO_0003677 | Molecular function | DNA binding |
| GO_0019899 | Molecular function | enzyme binding |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0003707 | Molecular function | nuclear steroid receptor activity |
| GO_0004879 | Molecular function | nuclear receptor activity |
| GO_0034056 | Molecular function | estrogen response element binding |
| GO_0008270 | Molecular function | zinc ion binding |
| GO_0005496 | Molecular function | steroid binding |
| GO_0048019 | Molecular function | receptor antagonist activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0030284 | Molecular function | nuclear estrogen receptor activity |
| Gene name | ESR2 |
| Protein name | Estrogen receptor beta Estrogen receptor beta (ER-beta) (Nuclear receptor subfamily 3 group A member 2) Estrogen receptor beta (Nuclear receptor subfamily 3 group A member 2) Estrogen receptor beta splice variant, ERbetaEx. 4L |
| Synonyms | NR3A2 hCG_21449 ESTRB |
| Description | FUNCTION: Nuclear hormone receptor. Binds estrogens with an affinity similar to that of ESR1/ER-alpha, and activates expression of reporter genes containing estrogen response elements (ERE) in an estrogen-dependent manner . .; FUNCTION: [Isoform 2]: Lacks ligand binding ability and has no or only very low ERE binding activity resulting in the loss of ligand-dependent transactivation ability. . |
| Accessions | ENST00000556275.5 Q92731 Q7LCB3 A0A679EN27 ENST00000554572.5 [Q92731-2] A0A348FV98 A0A348FV92 A0A348FV94 A0A348FV96 ENST00000344288.10 [Q92731-3] A0A348FV95 ENST00000555278.5 [Q92731-5] ENST00000267525.10 [Q92731-7] ENST00000353772.7 [Q92731-2] A0A348FV91 G3V5S2 A0A348FV97 ENST00000358599.9 [Q92731-2] ENST00000553796.5 [Q92731-9] ENST00000341099.6 [Q92731-1] ENST00000557772.5 [Q92731-6] A0A348FV93 |